[Updated guidelines of the Société de Pneumologie de Langue Française for the management of chronic obstructive pulmonary disease: essential points].
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003663:Decision Trees; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005602:France / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D010102:Oxygen Inhalation Therapy; D011013:Pneumonectomy; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D015272:Pulmonary Medicine / Q000379:methods* / Q000592:standards; D012307:Risk Factors; D012720:Severity of Illness Index; D012907:Smoking / Q000009:adverse effects; D013256:Steroids; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D013256:Steroids